"Closure of Aeon Sunway Pyramid won't have material impact on Aeon"
https://www.klsescreener.com/v2/news/view/1202801/closure-of-aeon-sunway-pyramid-won-039-t-have-material-impact-on-aeon
.
.
Aeon's property management segment's financial performance is expected to hold up with an increase in occupancy rate to 93 per cent by year end, and better rental renewal rate.

Additionally the resumption of business of Aeon Ayer Keroh and Aeon Cheras Selatan should support the growth.
.
.

Description CAPITALAND MALAYSIA TRUST ("CLMT")
- Revision of Trustee Fee
The Board of Directors (the “Board”) of CapitaLand Malaysia REIT Management Sdn. Bhd. (“CMRM”), the manager of CLMT, wishes to announce that the Trustee Fee of CLMT has been revised from the existing fee of RM400,000 per annum to RM440,000 per annum, with effect retrospectively from 1 July 2023 (the “Revision”).
~~~~~~~~~~~~~~~~~~~~~~~~~~

10% increase in trustee fee only 😰

@BursaVulture If this is the case, I think karma hit him hard. I know he was promoting SD very hard and has been written many articles when SD dropped, even later SD was suspended he kept on writing hysterically but I do not know in the earlier stage, he tried to push down the price for collection. He also keen to argue with others with different opinions aggressively. He probably bets on SD heavily and badly hurt.

November 2021 RW5,300 ?

Now RM3,713

@BursaVulture he wished to push down the price to collect?
and then, his wish come true ?

Zahid DNAA has thousands drawback but at least one good effect ---- prevent opportunist back to UMNO, he is impatient now and blame everyone not hit zahid hard enough !

Nice move 😃

FCPO (Nov) = RM 3683

Anyone remember Pearl_white?

Is Pearl_white still around? a few yrs ago, this is one of the favorites of the O&G expert.

No one cares about this?

nothing mentioned about the JV at Mexico 😐

is very normal of those holding in large pile keep on touting .... especially the price now ......

There is nothing new about part of the payment was received from the gov. and remain balance to be paid, ICPT is an ongoing process ...... the only thing is, it can only be registered to the account when the amount was received but the date and amount of the payment is depend on gov. .....

As at to date, TNB has already received full payment of the surcharge amounting to RM10.4 billion from the Government for the ICPT period from 1 January 2023 to 30 June 2023.

The Government has decided a total subsidy allocation of RM5.2 billion and introduced targeted subsidy scheme (‘Scheme’) for ICPT implementation period from 1 July 2023 until 31 December 2023.

Performance of the current second quarter (three months) FY2023 against the
corresponding second quarter (three months) FY2022:

Revenue for the quarter under review increased from RM12,837.7 million to RM13,323.2
million, resulted from higher sales of electricity by 3.5% or RM434.2 million.

Operating profit for the current quarter decreased by 28.9% or RM759.6 million due to
the lower ICPT under recovery recognised in the current quarter of RM2,860.2 million as
compared to RM6,302.6 million in the last corresponding quarter, offset by lower
operating expenses of RM2,328.1 million.

Profit after taxation decreased by RM634.7 million, from RM905.6 million in the last
corresponding period to RM270.9 million in the quarter under review. This was due to
negative fuel margins and foreign exchange translation losses in the current quarter.

~~~~~~~~~~~~~
Imbalance Cost Past-Through (ICPT) often creates unpredictable outcome 😐

Review of Performance

Revenue for the quarter improved by 4.2% compared to the corresponding second quarter of
2022, increased from RM 1.75 billion to RM 1.82 billion, while decreased by 7.2% against those of the preceding first quarter of 2023 which were RM 1.96 billion. The improved revenue in comparison to the corresponding second quarter of 2022 was due to higher sales recorded in Healthcare and Others segments coming from new clients and ongoing growth of existing clients in Healthcare segment and higher outlet sales for Others segment with resumption of batter supply. Revenue declined compared to the preceding first quarter of 2023, largely due to Ramadan being in early Q2 in Consumer Goods segment which created higher festive sales in preceding first quarter coupled with change in sales mix in Healthcare segment.

Operating expense for the quarter increased 4.8% from RM 1.70 billion to RM 1.79 billion
compared to the corresponding second quarter of 2022, while decreased by 6.6% against those of the preceding first quarter of 2023 which were at RM 1.91 billion. The changes in operating expenses were largely in line with the movement in revenue. The operating expense increased more than the revenue growth as compared to the corresponding second quarter of 2022 were largely due to higher cost base to support future growth.

Profit before tax for the quarter decreased by 23.9% compared to the same quarter of 2022 and decreased by 34.6% as compared to the preceding first quarter of 2023. The decline as
compared to the corresponding second quarter of 2022 was the outcome of higher operating
expense as above-mentioned and higher foreign exchange loss. The decrease in profit before
tax against preceding first quarter of 2023 was due to lower sales.

I compare it with same Q last year (also without Hari Raya),
Revenue increased but net profit dropped.

Is not fine tuned in many ways,
1. when reading the threads in forum mode, can't tab to access to the related counter info. The old App has this function at the top title bar.
2. while there are improvements in stock info page, only daily movement graph is shown. The old App has the options up to yearly graph.
3. always jam while typing longer ( I use desktop to type after failed twice)
4. until now, i can't find a way to organize counters in the portfolio in alphabetical order

At a glance, the QR like below expectation?

The release of chilled water to the sea from nuclear plant at Fukushima, would stricken all the seafood linked business including sushi.

will plunge to below 1.00 again!

DividendGuy67 > 5 days ago | Report Abuse

The TauRx relationship with Genting is very old story that went back to at least 2015 ... see here - https://www.biospace.com/article/releases/-b-taurx-pharmaceuticals-b-plans-u-s-ipo-/.

The "private value" of USD200-300 has been mentioned for many years. TauRx is a 30 year old "company".
.
.
.
The payoff might not be there. Don't buy GENTING just because it owned 20% of TauRx ... Buy GENTING for other reasons.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Thanks for the info. and fair advice

TauRx may lose to its rival, which already granted approvals

Eisai Azheimer’s drug set to win Japanese approval, after US
https://theedgemalaysia.com/node/679531

I don't know how many get the meaning wrong about this reporting.

Basically, the trio from east Malaysia were responded to a group of Muslim’s NGOs from peninsular, mainly from KL and Selangor, urged to establish a Malay-Muslim government without DAP ..... the east Malaysia organisations voiced their strong disagreement by saying that let the east Malaysia leaves Malaysia before that happens.

savemalaysia is not the author of this article, he merely serves i3 forum by pasted this article from focusmalaysia, a online portal. The original location of the article can be accessed through the link provided at the bottom of the article.

Reminder,
On behalf of the Board of the Manager, CIMB wishes to announce that the Proposed Placement has been completed following the listing and quotation of 464,997,500 Placement Units on the Main Market of Bursa Securities today. The issuance of the Placement Units raised gross proceeds of approximately RM227.85 million based on the issue price of RM0.49 each.

With the listing of the Placement Units, the total enlarged number of issued CLMT units is 2,671,932,995.

This announcement is dated 13 March 2023.

TauRx’s deliver Alzheimer’s disease therapy results
17th July 2023
Company’s hydromethylthionine mesylate therapy reduced neurodegeneration during pivotal trial

TauRx Pharmaceuticals – a company focused on Alzheimer’s disease (AD) research – has announced results from its pivotal phase 3 LUCIDITY trial.
.
.
Henrik Zetterberg, professor of neurochemistry at UCL Queen Square Institute of Neurology, concluded: “NfL is a well studied biomarker with wide applicability to different neurological disorders, including AD.

“Clinical practice has been waiting decades to uncover meaningful advancements to address unmet needs of people with AD. These new results further support the importance of NfL as an AD biomarker both for diagnosis and measurement of treatment effect.”

TauRx now intends to submit the HMTM results from LUCIDITY and previous trials for regulatory approval in the US, UK and several other territories.

Some info. about Taurx from google:
Where is TauRx located?
Singapore, TauRx is incorporated in Singapore with primary research and operations in Aberdeen, Scotland.

Who is the CEO of TauRx?
Professor Claude Wischik
For three decades, Professor Claude Wischik, co-founder and CEO of TauRx, has led a scientific research team dedicated to find an effective treatment for neurodegenerative disease. Professor Wischik is a board-certified psychiatrist and holder of a Chair in Mental Health at the University of Aberdeen.

OMG!! this group of nasty shameless thing still here to drag price

All JAKS holders Good Luck !

FCPO (Oct) = RM 3714

FCPO (Oct) = RM 3714

How to put the contents in the portfolio in alphabetical order?

FCPO (Oct) = RM 3763
drops from above 4000 last month

FCPO (Oct) = RM 3763
drops from above 4000 last month

Toyoven-WB
Expiry date = 06/11/2023 (~3 months left)
Exercise price = 1.50

If they keep the price above 1.50 (at least at that time), there would be conversion that could bring in >80m (53.495m x1.50) ..... otherwise WB would be ended as waste paper and they get nothing ;D

Proposed Special Dividend = 0.10
Proposed Capital Repayment = 0.75
Total = 0.85

Upon completion of the Proposed Disposal, PICB may be classified as a “Cash Company” and/or an “Affected Listed Issuer”. If so, the continuous listing of PICB on the Main Market of Bursa Securities is dependent on the ability of the Board and management to formulate a regularisation plan within the stipulated period.

On behalf of AEON Credit, AmInvestment Bank is pleased to announce that Bursa Securities had, vide its letter dated 31 July 2023, approved the listing of and quotation for 255,307,690 new ordinary shares to be issued pursuant to the Proposed Bonus Issue

if you don;t care, you won't create different IDs to support yourself lah .........

honest is the best policy, don't think that you can deceive other all the time

actually, you can register more IDs ..... so that, there would be more people support your argument

I also get this for other i3 forumers, seemed that many knew this

speakup
General Raider is not speakup
Speak up is not General Raider
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

If you are not stockraider, you won't be using the term like General Raider for him
you can deceive naive but not those sharp eyes

speakup, you are stockraider? you use different ID to support yourself?

Not sure how they are going to fulfill the 12. 50 % Bumis equity participation ..... if through new shares issuance, there would be another block of shares issued in low price, that poised for disposing ....

Don't intend to post here, just because coincidentally I did a little search on this counter, just drop a few lines, for those interested.

I would delay to go in, until a fair price. The RI with issued price @23.5 sen, was under subscribed by 27% (this probably taken up by under writer), the new shares still not listed. I suspect the price has been pushed up recently is for distribution preparation ;-)

This shows that Malays are cleverer than non-Malays, they untung but non-Malay rugi, very clever

70% of the sale of GCB is in local area (Malaysia, S'porem Indon) while the other 30% is in Germany /others. Local price is much lower (~30%) than the international price.

Malaysian cocoa price:
https://www.koko.gov.my/lkm/loader.cfm?page=19

can't remember exactly, like milo is one of the major customers of GCB

Below 1 again, good bargain?

FYE 30 June 2022
PAT 17,917
EPS = 18m/2.0b= 0.9 sen
P/E @26sen = 32.22

issue price of the above new listing shares : RM0.22